Cat. #154735
Anti-E2F4 [RK13]
Cat. #: 154735
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: E2F-4
Class: Monoclonal
Application: IHC ; IF ; IP ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Netherlands Cancer Institute
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-E2F4 [RK13]
- Alternate name: E2F Transcription Factor 4
- Research fields: Genetics
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 62 kDa
- Reactivity: Human
- Host: Mouse
- Application: IHC ; IF ; IP ; WB
- Description: E2F4 is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumour suppressor proteins and is also a target of the transforming proteins of small DNA tumour viruses. This protein binds to all three of the tumour suppressor proteins pRB, p107 and p130, but with higher affinity to the last two. It plays an important role in the suppression of proliferation-associated genes, and its gene mutation and increased expression may be associated with human cancer.
- Immunogen: Raised against amino acids 108-300 of E2F-4 of human origin
- Isotype: IgG2a
Target Details
- Target: E2F-4
- Molecular weight: 62 kDa
- Target background: E2F4 is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumour suppressor proteins and is also a target of the transforming proteins of small DNA tumour viruses. This protein binds to all three of the tumour suppressor proteins pRB, p107 and p130, but with higher affinity to the last two. It plays an important role in the suppression of proliferation-associated genes, and its gene mutation and increased expression may be associated with human cancer.
Applications
- Application: IHC ; IF ; IP ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Bindra et al. 2007. Oncogene. 26(14):2048-57. PMID: 17001309.